Xinrong Zhang (Juan Zhang)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Venues

Journal of medicinal chemistry

Cancer immunology, immunotherapy : CII

Molecular cancer research : MCR

Cancer research

China Pharmaceutical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

China Pharmaceutical University

China

PHD :: Molecular Biology

Publications

Chen Zhang, Jie Zhu, Xun Yuan, Zhengsheng Yan, Hui Ye, Tao Xiong, Anning Xu, Cunrui Li, Duorui Ji, Shan Yang, Xinrong Zhang, Yihua Zhang, Jianbing Wu, Zhangjian Huang
Development of Integrated Bioorthogonal Self-Catalyzed NO Donor/Platinum(IV) Prodrugs for Synergistical Intervention against Triple-Negative Breast Cancer. Journal of medicinal chemistry 67 (1) (2023)
Chen Zhang, Jie Zhu, Xun Yuan, Zhengsheng Yan, Hui Ye, Tao Xiong, Anning Xu, Cunrui Li, Duorui Ji, Shan Yang, Xinrong Zhang, Yihua Zhang, Jianbing Wu, Zhangjian Huang
Development of Integrated Bioorthogonal Self-Catalyzed NO Donor/Platinum(IV) Prodrugs for Synergistical Intervention against Triple-Negative Breast Cancer. Journal of medicinal chemistry (2023)
Peiwei Yang, Fan Yu, Zheng Yao, Xu Ding, Hanmei Xu, Xinrong Zhang
CD24 is a novel target of chimeric antigen receptor T cells for the treatment of triple negative breast cancer. Cancer immunology, immunotherapy : CII (2023)
Chen Zhang, Jie Zhu, Xun Yuan, Zhengsheng Yan, Hui Ye, Tao Xiong, Anning Xu, Cunrui Li, Duorui Ji, Shan Yang, Xinrong Zhang, Yihua Zhang, Jianbing Wu, Zhangjian Huang
Development of Integrated Bioorthogonal Self-Catalyzed NO Donor/Platinum(IV) Prodrugs for Synergistical Intervention against Triple-Negative Breast Cancer. Journal of medicinal chemistry 67 (1) (2023)
Chen Zhang, Jie Zhu, Xun Yuan, Zhengsheng Yan, Hui Ye, Tao Xiong, Anning Xu, Cunrui Li, Duorui Ji, Shan Yang, Xinrong Zhang, Yihua Zhang, Jianbing Wu, Zhangjian Huang
Development of Integrated Bioorthogonal Self-Catalyzed NO Donor/Platinum(IV) Prodrugs for Synergistical Intervention against Triple-Negative Breast Cancer. Journal of medicinal chemistry 67 (1) (2023)
Jianwei You, Xinrong Zhang, Jun Wang, Mingzhi Jin
Cysteine-Based Coupling: Challenges and Solutions. Bioconjugate chemistry 32 (8) (2021)
Manasik Gumah Ali, Zhening Zhang, Qi Gao, Mingzhu Pan, Edward G Rowan, Xinrong Zhang
Recent advances in therapeutic applications of neutralizing antibodies for virus infections: an overview. Immunologic research 68 (6) (2020)
Puregmaa Khongorzul, Cai Jia Ling, Farhan Ullah Khan, Awais Ullah Ihsan, Xinrong Zhang
Antibody-Drug Conjugates: A Comprehensive Review. Molecular cancer research : MCR 18 (1) (2019)
Fumou Sun, Yang Wang, Xiaojun Luo, Zhaoxiong Ma, Yao Xu, Xinrong Zhang, Tian Lv, Min Wang, Zhangjian Huang
Anti-CD24 Antibody-Nitric Oxide Conjugate Selectively and Potently Suppresses Hepatic Carcinoma. Cancer research 79 (13) (2019)
Yao Xu, Xinrong Zhang, Yong Wang, Mingzhu Pan, Min Wang, Xinrong Zhang
A VEGFR2-MICA bispecific antibody activates tumor-infiltrating lymphocytes and exhibits potent anti-tumor efficacy in mice. Cancer immunology, immunotherapy : CII 68 (9) (2019)

Xinrong Zhang.css-eqlu8i{font-size:small;padding-left:4px;} (Juan Zhang)

Publication Activity (10 Years)

Top Topics

Top Venues

Xinrong Zhang (Juan Zhang)